These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3018228

  • 1. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM, Haertzen CA, Johnson RE, Kocher T, Jasinski D.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [Abstract] [Full Text] [Related]

  • 2. Multidimensional scaling of subjective judgements of drug similarities among ketocyclazocine, morphine, cyclazocine, naloxone and placebo.
    Kumor KM, Clark WC, Janal MN, Haertzen CA.
    Pharmacol Biochem Behav; 1990 Feb; 35(2):397-404. PubMed ID: 2320648
    [Abstract] [Full Text] [Related]

  • 3. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
    Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE.
    J Pharmacol Exp Ther; 1976 Jun; 197(3):517-32. PubMed ID: 945347
    [Abstract] [Full Text] [Related]

  • 4. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [Abstract] [Full Text] [Related]

  • 5. A kappa opioid effect: increased urination in the rat.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM, Thompson DM.
    J Pharmacol Exp Ther; 1983 Sep; 226(3):738-48. PubMed ID: 6887010
    [Abstract] [Full Text] [Related]

  • 7. Morphine- and ketocyclazocine-induced analgesia in the developing rat: differences due to type of noxious stimulus and body topography.
    Giordano J, Barr GA.
    Brain Res; 1987 Apr; 429(2):247-53. PubMed ID: 3032373
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
    Gilbert PE, Martin WR.
    J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.
    Young GA, Khazan N.
    Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833
    [Abstract] [Full Text] [Related]

  • 15. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM, Holtzman SG.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of ketocyclazocine and ethylketocyclazocine on electric shock titration.
    Dykstra LA.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):19-26. PubMed ID: 6360694
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.